Glenda MacQueen, University of Toronto

Research

Biomarkers Major Depression Neuroimaging

Latest papers

THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.
Innovations in clinical neuroscience · 2020
The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder.
Innovations in clinical neuroscience · 2016
Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder.
Bipolar disorders · 2015

All 8 publications

Latest funding

Neurodevelopmental Risk for Anxiety and Mood Disorders in Pregnancy and the Post-Partum Period
CIHR · 2015 · Co-investigator
$1,005,787
Predicting Antidepressant Treatment Response in Major Depressive Disorder: An Integrated Clinical and Neuroimaging Approach
CIHR · 2012 · Principal investigator
$893,950
Neurodevelopmental Risk for Anxiety and Mood Disorders in Pregnancy and the Post-Partum Period
CIHR · 2010 · Co-investigator

All 3 grants and awards

8 publications.

01

THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.

Vaccarino AL, Kalali AH, Blier P, Gilbert Evans S, Engelhardt N, Foster JA, Frey BN, Greist JH, Kobak KA, Lam RW, MacQueen G, Milev R, Müller DJ, Parikh SV, Placenza FM, Rizvi SJ, Rotzinger S, Sheehan DV, Sills T, Soares CN, Turecki G, Uher R, Williams JBW, Kennedy SH, Evans KR

Innovations in clinical neuroscience2020

PMID: 33520402

02

The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder.

Vaccarino AL, Evans KR, Kalali AH, Kennedy SH, Engelhardt N, Frey BN, Greist JH, Kobak KA, Lam RW, MacQueen G, Milev R, Placenza FM, Ravindran AV, Sheehan DV, Sills T, Williams JB

Innovations in clinical neuroscience2016

PMID: 27974997

03

Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder.

Parikh SV, Hawke LD, Velyvis V, Zaretsky A, Beaulieu S, Patelis-Siotis I, MacQueen G, Young LT, Yatham LN, Cervantes P

Bipolar disorders2015

DOI: 10.1111/bdi.12233 PMID: 25046246

04

A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.

McIntyre RS, Soczynska JK, Woldeyohannes HO, Miranda A, Vaccarino A, Macqueen G, Lewis GF, Kennedy SH

Bipolar disorders2012

DOI: 10.1111/bdi.12006 PMID: 23107220

05

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders.

Rosenbluth M, Macqueen G, McIntyre RS, Beaulieu S, Schaffer A, Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists2012

PMID: 22303522

06

Bacterial infection causes stress-induced memory dysfunction in mice.

Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, Macqueen G, Sherman PM

Gut2011

DOI: 10.1136/gut.2009.202515 PMID: 20966022

07

Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression

Segal ZV, Bieling P, Young T, MacQueen G, Cooke R, Martin L, Bloch R, Levitan RD

JAMA psychiatry2010390 citations

DOI: 10.1001/archgenpsychiatry.2010.168

08

Coping styles in prodromes of bipolar mania

Parikh SV, Velyvis V, Yatham L, Beaulieu S, Cervantes P, MacQueen G, Siotis I, Streiner D, Zaretsky A

Bipolar Disorders200724 citations

DOI: 10.1111/j.1399-5618.2007.00448.x

Neurodevelopmental Risk for Anxiety and Mood Disorders in Pregnancy and the Post-Partum Period

Co-investigatorCIHR2015Operating Grant

Principal investigators: Rector, Neil A; Richter, Margaret A

Keywords: Anxiety Disorders; Cognition; Genetics; Mood Disorders; Neurodevelopmental; Perinatal; Personality; Vulnerability

$1,005,787

Predicting Antidepressant Treatment Response in Major Depressive Disorder: An Integrated Clinical and Neuroimaging Approach

Principal investigatorCIHR2012Operating Grant

Principal investigators: Kennedy, Sidney H; MacQueen, Glenda M

Keywords: Biomarkers; Major Depression; Neuroimaging

$893,950

Neurodevelopmental Risk for Anxiety and Mood Disorders in Pregnancy and the Post-Partum Period

Co-investigatorCIHR2010Team Grant - Maternal Health: From Pre-conception to the Empty Nest-LOI

Principal investigators: Rector, Neil A; Kennedy, James L; Richter, Margaret A

Keywords: Anxiety Disorders; Health Care Utilization; Knowledge Translation; Maternal Mental Health; Mood Disorders; Neurodevelopmental; Postpartum; Pregnancy; Prevalence; Vulnerability

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Psychiatry
Department of Psychiatry
Psychiatry & Behavioural Neurosciences
School of Nursing
Health Research Methods, Evidence, and Impact
Pediatrics
Cellular and Molecular Medicine
Other

Applying for

Paper to mention

Subject: Prospective PhD student: Biomarkers Dear Professor MacQueen, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial." (2020), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]